Author:
Kim Kook-Han,Lee Won-Kyu,Choi Kyung-Jae,Kim Eunice EunKyeong
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Biochemistry, Genetics and Molecular Biology
Reference32 articles.
1. Apfel CM, Locher H, Evers S, Takacs B, Hubschwerlen C, Pirson W, Page MG, and Keck W. (2001) Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother 45, 1058–64.
2. Aziz RK, Kansal R, Aronow BJ, Taylor WL, Rowe SL, Kubal M, Chhatwal GS, Walker MJ, and Kotb M. (2010) Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence. PLoS One 5, e9798.
3. Baldwin ET, Harris MS, Yem AW, Wolfe CL, Vosters AF, Curry KA, Murray RW, Bock JH, Marshall VP, Cialdella JI, Merchant MH, Choi G, and Deibel MR. (2002) Crystal structure of type II peptide deformylase from Staphylococcus aureus. J Biol Chem 277, 31163–71.
4. Becker A, Schlichting I, Kabsch W, Groche D, Schultz S, and Wagner AF. (1998) Iron center, substrate recognition and mechanism of peptide deformylase. Nat Struct Biol 5, 1053–8.
5. Boularot A, Giglione C, Artaud I, and Meinnel T. (2004) Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors. Curr Opin Investig Drugs 5, 809–22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献